NCT00488488View on ClinicalTrials.gov

A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting

CompletedOBSERVATIONAL

Enrollment

1,028

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Infection

Interventions

DRUG

tigecycline

The patients will be treated in accordance with the requirements of the labeling of tigecycline in Germany. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment.